In agreement with this suggestion, our examination of CEGRs/ALCDs-independent REG3A showed that its mRNA is highly elevated in HBL patients with an active ph-S675-β-catenin-TCF4 pathway (Figure 2E). This evidence concerns the gene REG3A and hepatoblastoma.